ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,724.30
-0.33%
S&P ASX All Technology
3,092.70
-1.13%
Brent Oil
82.275
0.00%
US Dollar vs AUD
1.51378
0.08%
Bitcoin
66,299.99
0.45%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU
  6. PHAXIAM Therapeutics SA (PHXM)

  7. PHAXIAM Therapeutics SA (PHXM) News

PHXM

PHAXIAM Therapeutics (PHXM)

PHAXIAM Therapeutics SA
Date:
Sort by:
 Showing the most relevant articles for your search:EU:PHXM
DateTimeSourceHeadlineSymbolCompany
12/06/202416:00GlobeNewswire Inc.Lancement d'une augmentation de capital avec maintien du DPS d’un montant d’environ 10 M€, susceptible d’être porté à environ 11,5 M€ en cas d’exercice intégral de la clause d'extensionEU:PHXMPHAXIAM Therapeutics SA
08/06/202401:45GlobeNewswire Inc.PHAXIAM annonce les modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 28 juin 2024EU:PHXMPHAXIAM Therapeutics SA
08/06/202401:45GlobeNewswire Inc.PHAXIAM announces the availability of the preparatory documents for the Combined General Meeting of 28 June 2024EU:PHXMPHAXIAM Therapeutics SA
06/06/202402:00GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2024EU:PHXMPHAXIAM Therapeutics SA
06/06/202402:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – May 31, 2024EU:PHXMPHAXIAM Therapeutics SA
16/05/202401:45GlobeNewswire Inc.PHAXIAM Therapeutics fait le point sur ses activités et publie l’information financière du premier trimestre 2024EU:PHXMPHAXIAM Therapeutics SA
16/05/202401:45GlobeNewswire Inc.PHAXIAM provides Business and Financial Update for the First Quarter of 2024EU:PHXMPHAXIAM Therapeutics SA
04/05/202402:05GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2024EU:PHXMPHAXIAM Therapeutics SA
04/05/202402:05GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2024EU:PHXMPHAXIAM Therapeutics SA
15/04/202415:30GlobeNewswire Inc.PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureusEU:PHXMPHAXIAM Therapeutics SA
15/04/202415:30GlobeNewswire Inc.PHAXIAM Therapeutics annonce le recrutement du premier patient dans l’étude de phase 1 dans l’endocardite infectieuse causée par le Staphylococcus aureusEU:PHXMPHAXIAM Therapeutics SA
10/04/202402:00GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 mars 2024EU:PHXMPHAXIAM Therapeutics SA
10/04/202402:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – March 29, 2024EU:PHXMPHAXIAM Therapeutics SA
06/04/202403:00GlobeNewswire Inc.PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)EU:PHXMPHAXIAM Therapeutics SA
06/04/202403:00GlobeNewswire Inc.PHAXIAM Therapeutics annonce le dépôt de son Document d’Enregistrement Universel (URD) 2023EU:PHXMPHAXIAM Therapeutics SA
11/03/202417:00GlobeNewswire Inc.PHAXIAM Therapeutics annonce la réalisation du retrait volontaire de ses « American Depository Shares » du Nasdaq Stock MarketEU:PHXMPHAXIAM Therapeutics SA
11/03/202417:00GlobeNewswire Inc.PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock MarketEU:PHXMPHAXIAM Therapeutics SA
11/03/202417:00GlobeNewswire Inc.PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock MarketEU:PHXMPHAXIAM Therapeutics SA
06/03/202404:00GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 février 2024EU:PHXMPHAXIAM Therapeutics SA
06/03/202404:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - February 29, 2024EU:PHXMPHAXIAM Therapeutics SA
21/02/202408:05GlobeNewswire Inc.PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketEU:PHXMPHAXIAM Therapeutics SA
21/02/202408:05GlobeNewswire Inc.PHAXIAM Therapeutics annonce son intention de procéder au retrait volontaire de ses « American Depositary Shares » du Nasdaq Capital MarketEU:PHXMPHAXIAM Therapeutics SA
21/02/202408:05GlobeNewswire Inc.PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketEU:PHXMPHAXIAM Therapeutics SA
07/02/202408:05GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - January 31, 2024EU:PHXMPHAXIAM Therapeutics SA
07/02/202408:05GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2024EU:PHXMPHAXIAM Therapeutics SA
19/01/202408:05GlobeNewswire Inc.PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024EU:PHXMPHAXIAM Therapeutics SA
19/01/202408:05GlobeNewswire Inc.PHAXIAM Therapeutics annonce son niveau de trésorerie à fin 2023 et son calendrier financier 2024EU:PHXMPHAXIAM Therapeutics SA
19/01/202408:05GlobeNewswire Inc.PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024EU:PHXMPHAXIAM Therapeutics SA
04/01/202408:05GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2023EU:PHXMPHAXIAM Therapeutics SA
04/01/202408:05GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - December 31, 2023EU:PHXMPHAXIAM Therapeutics SA
 Showing the most relevant articles for your search:EU:PHXM

Your Recent History

ASX
CSL
CSL
ASX
WES
Wesfarmers
ASX
WPL
Woodside Petroleum
ASX
WBC
Westpac Banking
FX
AUDCAD
AUD vs CAD
FX
AUDJPY
AUD vs Yen
NASDAQ
AMZN
Amazon.com
NYSE
KO
Coca Cola
NASDAQ
AAPL
Apple
NYSE
JPM
JP Morgan Chase
ASX
XMM
S&P ASX 300 Metals and M...
SPI
SP500
S&P 500
NYSE
VZ
Verizon Communications
ASX
AMP
AMP
ASX
XFL
S&P ASX 50
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved